AIM ImmunoTech Inc.
AIMI
$0.0807
$0.012718.68%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 28.57% | -30.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 28.57% | -30.00% | |||
| Cost of Revenue | -12.50% | 0.00% | |||
| Gross Profit | 40.74% | -35.71% | |||
| SG&A Expenses | 40.21% | 18.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.42% | 20.83% | |||
| Operating Income | -30.43% | -21.52% | |||
| Income Before Tax | -61.27% | -101.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -61.27% | -101.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -61.27% | -101.53% | |||
| EBIT | -30.43% | -21.52% | |||
| EBITDA | -30.84% | -21.83% | |||
| EPS Basic | -45.17% | -85.01% | |||
| Normalized Basic EPS | -30.86% | -108.21% | |||
| EPS Diluted | -45.17% | -85.01% | |||
| Normalized Diluted EPS | -30.86% | -108.21% | |||
| Average Basic Shares Outstanding | 10.99% | 9.16% | |||
| Average Diluted Shares Outstanding | 10.99% | 9.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||